Pharmacoeconomic analysis of topical treatments for tinea infections

International Journal of Dermatology

Volumn 37, Issue 1, 1998, Pages 64-71

  Shear, Neil H ^b   Einarson, Thomas R ^b   Arikian, Steven R ^a   Doyle, John J ^b   Van Assche, Daniel ^b  

^a Health Economics Research   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CICLOPIROX; CLOTRIMAZOLE; KETOCONAZOLE; MICONAZOLE; TERBINAFINE;

ARTICLE; AUSTRIA; CLINICAL TRIAL; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DERMATOMYCOSIS; GERMANY; HUMAN; META ANALYSIS; MYCOSIS; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PHASE 4 CLINICAL TRIAL; RELAPSE; SWITZERLAND; TINEA; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANTIFUNGAL AGENTS; CLINICAL TRIALS; COST-BENEFIT ANALYSIS; DRUG COSTS; HUMANS; META-ANALYSIS; OUTCOME ASSESSMENT (HEALTH CARE); TINEA;

EID: 0031918104     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.1998.00089.x     Document Type: Article

References (25)

1. Balfour JA, Faulds D. Terbinafine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial mycoses. Drugs 1992; 43: 259-284.
2. Leyden JJ. Progression of interdigital infections from simplex to complex. J Am Acad Dermatol 1993; 28: S7-S11.
3. Jue SG, Dawson GW, Brogden RN. Ciclopirox olamine 1% cream a preliminary review of its antimicrobial activity and therapeutic use. Drugs 1985; 29: 330-341.
4. Schuster I, Ryder NS. Allylamines - mode and selectivity of action compared to azole antifungals and biological fate in mammals. J Derm Treat 1990; 1 (Suppl. 2): 7-9.
5. Arikian S, Einarson TR, Kobelt-Nguyen G, Schubert F. A multinational pharmacoeconomic analysis of oral therapies for onychomycosis. Br J Dermatol 1994; 130 (Suppl. 43): 35-44.
6. Laupacis A, Feeny D, Detsky AS, et al. How attractive does new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. Can Med Assoc J 1992; 146: 473-481.
7. Hillman Al, Eisenberg JM, Pauly MV, et al. Avoiding bias in the conduct and reporting of cost effectiveness research sponsored by pharmaceutical companies. N Engl J Med 1991; 324: 1362-1363.
8. Einarson TR, Leeder JS, Koren G. A method for meta-analysis of epidemiologic studies. Drug Intell Clin Pharm 1988; 22: 813-824.
9. Velanovich V. Meta-analysis for combining Bayesian probabilities. Med Hypoth 1991; 35: 192-195.
10. Fredriksson T, Savopoulos C. Doppelblind-vergleichsstudie mit ciclopiroxolamin-creme und plazebo-creme bei dermatophytosen. Drug Res 1981; 31: 1376-1378.
11. Shimazaki T. Clinical evaluation of ciclopirox-olamine on tinea cruris. Nichinihon J Dermatol 1978; 40: 351-355.
12. Tarle SF. Estudo comparative duplo-cego com ciclopirox e clotrimazol sub as formas de creme no tratamento das micosas superficias. Rev Bras Med 1980; 316-321.
13. Bogaert H, Cordero C, Ollague W, et al. Multicentre double-blind clinical trials of ciclopirox olamine cream 1% in the treatment of tinea corporis and tinea cruris. J Int Med Res 1986; 14: 210-216.
14. Smith EB, Graham JL, Ulrich JA. Topical clotrimazole in tinea pedis. South Med J 1977; 70: 47-48.
15. Van Dersarl JV, Sheppard RH. Clotrimazole vs haloprogin treatment of tinea cruris. Arch Dermatol 1977; 13: 1233-1235.
16. Greer DL, Jolly HW. Treatment of tinea cruris with topical terbinafine. J Am Acad Dermatol 1990; 4: 800-804.
17. Avila JM. Treatment of dermatomycoses with sulconazole 1% nitrate cream or miconazole nitrate 2% cream. A double-blind comparative study. Curr Ther Res 1985; 38: 328-333.
18. Fredriksson (1983)
19. Gentles JC, Jones GR, Roberts DT. Efficacy of miconazole in the topical treatment of tinea pedis in sportsmen. Br J Dermatol 1975; 93: 79-84.
20. Ongley RC. Efficacy of topical miconazole treatment of tinea pedis. Can Med Assoc J 1978; 119: 353-354.
21. Tanenbaum L, Anderson C, Rosenberg MJ, et al. Sulconazole nitrate 1.0 percent cream: a comparison with miconazole in the treatment of tinea pedis and tinea cruris/corporis. Cutis 1982; 30: 105-107, 115, 118.
22. Berman B, Ellis C, Leyden J, et al. Efficacy of a 1-week, twice-daily regimen of terbinafine 1% cream in the treatment of interdigital tinea pedis. J Am Acad Dermatol 1992; 26: 956-960.
23. Evans EGV, Dodman B, Williamson DM, et al. A double-blind comparison of one week of terbinafine 1% cream compared to four weeks of clotrimazole 1% cream in the treatment of tinea pedis. BMJ 1993; 307: 645-647.
24. Millikan LE. Efficacy and tolerability of topical terbinafine in the treatment of tinea cruris. J Am Acad Dermatol 1990; 23: 795-799.
25. Bergstresser PR, Elewski B, Hanifin J. Topical terbinafine and clotrimazole in tinea pedis. Comparison of cure and relapse rates with 1- and 4-week regimens of terbinafine and clotrimazole 1% cream in patients with interdigital tinea pedis: results of a double-blind, multicenter trial. J Am Acad Dermatol 1993; 28: 648-651.